Cardiovascular biomarkers predict susceptibility to lung injury in World Trade Center dust-exposed firefighters
Year: 2012
Type: article
Study design: Observational Study
Abstract: Pulmonary vascular loss is an early feature of chronic obstructive pulmonary disease. Biomarkers of inflammation and of metabolic syndrome predict loss of lung function in World Trade Center (WTC) lung injury (LI). We investigated if other cardiovascular disease (CVD) biomarkers also predicted WTC-LI. This nested case-cohort study used 801 never-smoker, WTC-exposed firefighters with normal pre-9/11 lung function presenting for subspecialty pulmonary evaluation (SPE) before March 2008. A representative subcohort of 124 out of 801 subjects with serum drawn within 6 months of 9/11 defined CVD biomarker distribution. Post-9/11 forced expiratory volume in 1 s (FEV1) at defined cases were as follows: susceptible WTC-LI cases with FEV1 ≤77% predicted (66 out of 801) and resistant WTC-LI cases with FEV1 ≥107% predicted (68 out of 801). All models were adjusted for WTC exposure intensity, body mass index at SPE, age on 9/11 and pre-9/11 FEV1. Susceptible WTC-LI cases had higher levels of apolipoprotein-AII, C-reactive protein and macrophage inflammatory protein-4 with significant relative risks (RRs) of 3.85, 3.93 and 0.26, respectively, with an area under the curve (AUC) of 0.858. Resistant WTC-LI cases had significantly higher soluble vascular cell adhesion molecule and lower myeloperoxidase, with RRs of 2.24 and 2.89, respectively (AUC 0.830). Biomarkers of CVD in serum 6 months post-9/11 predicted either susceptibility or resistance to WTC-LI. These biomarkers may define pathways either producing or protecting subjects from pulmonary vascular disease and associated loss of lung function after an irritant exposure.
Source: European Respiratory Journal
Language: English
Subfield: Occupational Therapy
Field: Health Professions
Domain: Health Sciences
Open Access status: bronze
Funders: National Institutes of Health, U.S. Public Health Service, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences, National Center for Research Resources, National Institute for Occupational Safety and Health, National Center for Advancing Translational Sciences
Awards: HIV activation in secondary pulmonary infection, G1809097787, G232469090, G386597006, Institutional Clinical and Translational Science Award, Institutional Clinical and Translational Science Award, Longtitudinal Studies of HIV-Associated Bacterial Pneumonia, CD80 and CD86 mediated innate immune response in sepsis, Institutional Clinical and Translational Science Award, Translational Research Training in Environmental Medicine, G6016809231, HIV/TB Interaction in the Lung
OpenAlex ID: W2154639940
